In addition, western blot further suggested that the expression of CyclinD1 and CDK4 in cervical cancer cells derived CSCs treated with zoledronic acid was decreased in dose-dependent manners (Fig. 5c). The gene discussed is CCND1; the disease is cervical carcinoma.